Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

496 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
ERBB4-mediated signaling is a mediator of resistance to BTK and PI3K inhibitors in B cell lymphoid neoplasms.
Arribas AJ, Napoli S, Cascione L, Barnabei L, Sartori G, Cannas E, Gaudio E, Tarantelli C, Mensah AA, Spriano F, Zucchetto A, Rossi FM, Rinaldi A, de Moura MC, Jovic S, Pittau RB, Stathis A, Stussi G, Gattei V, Brown JR, Esteller M, Zucca E, Rossi D, Bertoni F. Arribas AJ, et al. Among authors: zucca e. bioRxiv [Preprint]. 2023 Jan 2:2023.01.01.522017. doi: 10.1101/2023.01.01.522017. bioRxiv. 2023. Update in: Mol Cancer Ther. 2024 Mar 4;23(3):368-380. doi: 10.1158/1535-7163.MCT-23-0068. PMID: 36711490 Free PMC article. Updated. Preprint.
Mantle cell lymphoma.
Bertoni F, Zucca E, Cavalli F. Bertoni F, et al. Among authors: zucca e. Curr Opin Hematol. 2004 Nov;11(6):411-8. doi: 10.1097/01.moh.0000138682.13354.da. Curr Opin Hematol. 2004. PMID: 15548996 Review.
Another Piece of the MALT Lymphomas Jigsaw.
Zucca E, Bertoni F. Zucca E, et al. J Clin Oncol. 2005 Aug 1;23(22):4832-4. doi: 10.1200/JCO.2005.92.007. Epub 2005 Jun 20. J Clin Oncol. 2005. PMID: 15968002 No abstract available.
Delving deeper into MALT lymphoma biology.
Bertoni F, Zucca E. Bertoni F, et al. Among authors: zucca e. J Clin Invest. 2006 Jan;116(1):22-6. doi: 10.1172/JCI27476. J Clin Invest. 2006. PMID: 16395399 Free PMC article.
Bendamustine in lymphomas: more to combine?
Bertoni F, Zucca E. Bertoni F, et al. Among authors: zucca e. Leuk Lymphoma. 2007 Jul;48(7):1264-6. doi: 10.1080/10428190701472021. Leuk Lymphoma. 2007. PMID: 17613752 No abstract available.
Marginal zone lymphomas.
Zucca E, Bertoni F, Stathis A, Cavalli F. Zucca E, et al. Hematol Oncol Clin North Am. 2008 Oct;22(5):883-901, viii. doi: 10.1016/j.hoc.2008.07.011. Hematol Oncol Clin North Am. 2008. PMID: 18954742 Review.
Treatment of gastric marginal zone lymphoma of MALT type.
Stathis A, Bertoni F, Zucca E. Stathis A, et al. Among authors: zucca e. Expert Opin Pharmacother. 2010 Sep;11(13):2141-52. doi: 10.1517/14656566.2010.497141. Expert Opin Pharmacother. 2010. PMID: 20586708 Review.
Del(13q14.3) length matters: an integrated analysis of genomic, fluorescence in situ hybridization and clinical data in 169 chronic lymphocytic leukaemia patients with 13q deletion alone or a normal karyotype.
Mian M, Rinaldi A, Mensah AA, Rossi D, Ladetto M, Forconi F, Marasca R, Gattei V, Zucca E, Cavalli F, Gaidano G, Kwee I, Bertoni F. Mian M, et al. Among authors: zucca e. Hematol Oncol. 2012 Mar;30(1):46-9. doi: 10.1002/hon.997. Epub 2011 Jun 13. Hematol Oncol. 2012. PMID: 21671253 No abstract available.
Absence of NOTCH1 gene mutations in MALT lymphomas.
Mensah AA, Rinaldi A, Ponzoni M, Canzonieri V, Uccella S, Rossi D, Bhagat G, Gaidano G, Zucca E, Bertoni F. Mensah AA, et al. Among authors: zucca e. Br J Haematol. 2012 May;157(3):382-4. doi: 10.1111/j.1365-2141.2011.08980.x. Epub 2011 Dec 16. Br J Haematol. 2012. PMID: 22171922 No abstract available.
MALT lymphomas: pathogenesis can drive treatment.
Bertoni F, Coiffier B, Salles G, Stathis A, Traverse-Glehen A, Thieblemont C, Zucca E. Bertoni F, et al. Among authors: zucca e. Oncology (Williston Park). 2011 Nov 15;25(12):1134-42, 1147. Oncology (Williston Park). 2011. PMID: 22229204 Free article. Review.
MYD88 somatic mutations in MALT lymphomas.
Li ZM, Rinaldi A, Cavalli A, Mensah AA, Ponzoni M, Gascoyne RD, Bhagat G, Zucca E, Bertoni F. Li ZM, et al. Among authors: zucca e. Br J Haematol. 2012 Sep;158(5):662-4. doi: 10.1111/j.1365-2141.2012.09176.x. Epub 2012 May 29. Br J Haematol. 2012. PMID: 22640364 No abstract available.
The changing paradigm of chronic lymphocytic leukemia management.
Lobetti-Bodoni C, Bertoni F, Stussi G, Cavalli F, Zucca E. Lobetti-Bodoni C, et al. Among authors: zucca e. Eur J Intern Med. 2013 Jul;24(5):401-10. doi: 10.1016/j.ejim.2013.03.009. Epub 2013 Apr 11. Eur J Intern Med. 2013. PMID: 23583413 Review.
Promoter methylation patterns in Richter syndrome affect stem-cell maintenance and cell cycle regulation and differ from de novo diffuse large B-cell lymphoma.
Rinaldi A, Mensah AA, Kwee I, Forconi F, Orlandi EM, Lucioni M, Gattei V, Marasca R, Berger F, Cogliatti S, Cavalli F, Zucca E, Gaidano G, Rossi D, Bertoni F. Rinaldi A, et al. Among authors: zucca e. Br J Haematol. 2013 Oct;163(2):194-204. doi: 10.1111/bjh.12515. Epub 2013 Aug 21. Br J Haematol. 2013. PMID: 23961875
The management of nongastric MALT lymphomas.
Zucca E, Stathis A, Bertoni F. Zucca E, et al. Oncology (Williston Park). 2014 Jan;28(1):86-93. Oncology (Williston Park). 2014. PMID: 24683726 Free article. Review. No abstract available.
DNA methylation profiling identifies two splenic marginal zone lymphoma subgroups with different clinical and genetic features.
Arribas AJ, Rinaldi A, Mensah AA, Kwee I, Cascione L, Robles EF, Martinez-Climent JA, Oscier D, Arcaini L, Baldini L, Marasca R, Thieblemont C, Briere J, Forconi F, Zamò A, Bonifacio M, Mollejo M, Facchetti F, Dirnhofer S, Ponzoni M, Bhagat G, Piris MA, Gaidano G, Zucca E, Rossi D, Bertoni F. Arribas AJ, et al. Among authors: zucca e. Blood. 2015 Mar 19;125(12):1922-31. doi: 10.1182/blood-2014-08-596247. Epub 2015 Jan 22. Blood. 2015. PMID: 25612624 Free PMC article.
The BET Bromodomain Inhibitor OTX015 Affects Pathogenetic Pathways in Preclinical B-cell Tumor Models and Synergizes with Targeted Drugs.
Boi M, Gaudio E, Bonetti P, Kwee I, Bernasconi E, Tarantelli C, Rinaldi A, Testoni M, Cascione L, Ponzoni M, Mensah AA, Stathis A, Stussi G, Riveiro ME, Herait P, Inghirami G, Cvitkovic E, Zucca E, Bertoni F. Boi M, et al. Among authors: zucca e. Clin Cancer Res. 2015 Apr 1;21(7):1628-38. doi: 10.1158/1078-0432.CCR-14-1561. Epub 2015 Jan 26. Clin Cancer Res. 2015. PMID: 25623213
Management of the marginal zone lymphomas.
Vannata B, Stathis A, Zucca E. Vannata B, et al. Among authors: zucca e. Cancer Treat Res. 2015;165:227-49. doi: 10.1007/978-3-319-13150-4_9. Cancer Treat Res. 2015. PMID: 25655612 Review.
PQR309 Is a Novel Dual PI3K/mTOR Inhibitor with Preclinical Antitumor Activity in Lymphomas as a Single Agent and in Combination Therapy.
Tarantelli C, Gaudio E, Arribas AJ, Kwee I, Hillmann P, Rinaldi A, Cascione L, Spriano F, Bernasconi E, Guidetti F, Carrassa L, Pittau RB, Beaufils F, Ritschard R, Rageot D, Sele A, Dossena B, Rossi FM, Zucchetto A, Taborelli M, Gattei V, Rossi D, Stathis A, Stussi G, Broggini M, Wymann MP, Wicki A, Zucca E, Cmiljanovic V, Fabbro D, Bertoni F. Tarantelli C, et al. Among authors: zucca e. Clin Cancer Res. 2018 Jan 1;24(1):120-129. doi: 10.1158/1078-0432.CCR-17-1041. Epub 2017 Oct 24. Clin Cancer Res. 2018. PMID: 29066507
Circulating tumor DNA reveals genetics, clonal evolution, and residual disease in classical Hodgkin lymphoma.
Spina V, Bruscaggin A, Cuccaro A, Martini M, Di Trani M, Forestieri G, Manzoni M, Condoluci A, Arribas A, Terzi-Di-Bergamo L, Locatelli SL, Cupelli E, Ceriani L, Moccia AA, Stathis A, Nassi L, Deambrogi C, Diop F, Guidetti F, Cocomazzi A, Annunziata S, Rufini V, Giordano A, Neri A, Boldorini R, Gerber B, Bertoni F, Ghielmini M, Stüssi G, Santoro A, Cavalli F, Zucca E, Larocca LM, Gaidano G, Hohaus S, Carlo-Stella C, Rossi D. Spina V, et al. Among authors: zucca e. Blood. 2018 May 31;131(22):2413-2425. doi: 10.1182/blood-2017-11-812073. Epub 2018 Feb 15. Blood. 2018. PMID: 29449275 Free article.
Bromodomain and extra-terminal domain inhibition modulates the expression of pathologically relevant microRNAs in diffuse large B-cell lymphoma.
Mensah AA, Cascione L, Gaudio E, Tarantelli C, Bomben R, Bernasconi E, Zito D, Lampis A, Hahne JC, Rinaldi A, Stathis A, Zucca E, Kwee I, Gattei V, Valeri N, Riveiro ME, Bertoni F. Mensah AA, et al. Among authors: zucca e. Haematologica. 2018 Dec;103(12):2049-2058. doi: 10.3324/haematol.2018.191684. Epub 2018 Aug 3. Haematologica. 2018. PMID: 30076183 Free PMC article.
BET bromodomain inhibitor birabresib in mantle cell lymphoma: in vivo activity and identification of novel combinations to overcome adaptive resistance.
Tarantelli C, Bernasconi E, Gaudio E, Cascione L, Restelli V, Arribas AJ, Spriano F, Rinaldi A, Mensah AA, Kwee I, Ponzoni M MD, Zucca E, Carrassa L, Riveiro ME, Rezai K, Stathis A, Cvitkovic E, Bertoni F. Tarantelli C, et al. Among authors: zucca e. ESMO Open. 2018 Sep 26;3(6):e000387. doi: 10.1136/esmoopen-2018-000387. eCollection 2018. ESMO Open. 2018. PMID: 30305939 Free PMC article.
Foreword.
Rossi D, Zucca E. Rossi D, et al. Among authors: zucca e. Eur J Intern Med. 2018 Dec;58:1. doi: 10.1016/j.ejim.2018.11.006. Epub 2018 Nov 27. Eur J Intern Med. 2018. PMID: 30501918 No abstract available.
The Bruton tyrosine kinase inhibitor zanubrutinib (BGB-3111) demonstrated synergies with other anti-lymphoma targeted agents.
Tarantelli C, Zhang L, Curti E, Gaudio E, Spriano F, Priebe V, Cascione L, Arribas AJ, Zucca E, Rossi D, Stathis A, Bertoni F. Tarantelli C, et al. Among authors: zucca e. Haematologica. 2019 Jul;104(7):e307-e309. doi: 10.3324/haematol.2018.214759. Epub 2019 Jan 24. Haematologica. 2019. PMID: 30679329 Free PMC article. No abstract available.
Genome-wide promoter methylation of hairy cell leukemia.
Arribas AJ, Rinaldi A, Chiodin G, Kwee I, Mensah AA, Cascione L, Rossi D, Kanduri M, Rosenquist R, Zucca E, Johnson PW, Gaidano G, Oakes CC, Bertoni F, Forconi F. Arribas AJ, et al. Among authors: zucca e. Blood Adv. 2019 Feb 12;3(3):384-396. doi: 10.1182/bloodadvances.2018024059. Blood Adv. 2019. PMID: 30723113 Free PMC article.
The novel CD19-targeting antibody-drug conjugate huB4-DGN462 shows improved anti-tumor activity compared to SAR3419 in CD19-positive lymphoma and leukemia models.
Hicks SW, Tarantelli C, Wilhem A, Gaudio E, Li M, Arribas AJ, Spriano F, Bordone R, Cascione L, Lai KC, Qiu Q, Taborelli M, Rossi D, Stussi G, Zucca E, Stathis A, Sloss CM, Bertoni F. Hicks SW, et al. Among authors: zucca e. Haematologica. 2019 Aug;104(8):1633-1639. doi: 10.3324/haematol.2018.211011. Epub 2019 Feb 7. Haematologica. 2019. PMID: 30733273 Free PMC article.
Novel insights into the genetics and epigenetics of MALT lymphoma unveiled by next generation sequencing analyses.
Cascione L, Rinaldi A, Bruscaggin A, Tarantelli C, Arribas AJ, Kwee I, Pecciarini L, Mensah AA, Spina V, Chung EYL, di Bergamo LT, Dirnhofer S, Tzankov A, Miranda RN, Young KH, Traverse-Glehen A, Gaidano G, Swerdlow SH, Gascoyne R, Rabadan R, Ponzoni M, Bhagat G, Rossi D, Zucca E, Bertoni F. Cascione L, et al. Among authors: zucca e. Haematologica. 2019 Dec;104(12):e558-e561. doi: 10.3324/haematol.2018.214957. Epub 2019 Apr 24. Haematologica. 2019. PMID: 31018978 Free PMC article. No abstract available.
The Novel TORC1/2 Kinase Inhibitor PQR620 Has Anti-Tumor Activity in Lymphomas as a Single Agent and in Combination with Venetoclax.
Tarantelli C, Gaudio E, Hillmann P, Spriano F, Sartori G, Aresu L, Cascione L, Rageot D, Kwee I, Beaufils F, Zucca E, Stathis A, Wymann MP, Cmiljanovic V, Fabbro D, Bertoni F. Tarantelli C, et al. Among authors: zucca e. Cancers (Basel). 2019 Jun 4;11(6):775. doi: 10.3390/cancers11060775. Cancers (Basel). 2019. PMID: 31167506 Free PMC article.
The ETS Inhibitors YK-4-279 and TK-216 Are Novel Antilymphoma Agents.
Spriano F, Chung EYL, Gaudio E, Tarantelli C, Cascione L, Napoli S, Jessen K, Carrassa L, Priebe V, Sartori G, Graham G, Selvanathan SP, Cavalli A, Rinaldi A, Kwee I, Testoni M, Genini D, Ye BH, Zucca E, Stathis A, Lannutti B, Toretsky JA, Bertoni F. Spriano F, et al. Among authors: zucca e. Clin Cancer Res. 2019 Aug 15;25(16):5167-5176. doi: 10.1158/1078-0432.CCR-18-2718. Epub 2019 Jun 10. Clin Cancer Res. 2019. PMID: 31182435
Copanlisib synergizes with conventional and targeted agents including venetoclax in B- and T-cell lymphoma models.
Tarantelli C, Lange M, Gaudio E, Cascione L, Spriano F, Kwee I, Arribas AJ, Rinaldi A, Jourdan T, Berthold M, Sturz A, Sperl C, Margheriti F, Scalise L, Gritti G, Rossi D, Stathis A, Liu N, Zucca E, Politz O, Bertoni F. Tarantelli C, et al. Among authors: zucca e. Blood Adv. 2020 Mar 10;4(5):819-829. doi: 10.1182/bloodadvances.2019000844. Blood Adv. 2020. PMID: 32126142 Free PMC article.
Marginal Zone Lymphomas.
Bertoni F, Rossi D, Raderer M, Zucca E. Bertoni F, et al. Among authors: zucca e. Cancer J. 2020 Jul/Aug;26(4):336-347. doi: 10.1097/PPO.0000000000000463. Cancer J. 2020. PMID: 32732678 Review.
Antitumor activity of the dual BET and CBP/EP300 inhibitor NEO2734.
Spriano F, Gaudio E, Cascione L, Tarantelli C, Melle F, Motta G, Priebe V, Rinaldi A, Golino G, Mensah AA, Aresu L, Zucca E, Pileri S, Witcher M, Brown B, Wahlestedt C, Giles F, Stathis A, Bertoni F. Spriano F, et al. Among authors: zucca e. Blood Adv. 2020 Sep 8;4(17):4124-4135. doi: 10.1182/bloodadvances.2020001879. Blood Adv. 2020. PMID: 32882003 Free PMC article.
Targeting CD205 with the antibody drug conjugate MEN1309/OBT076 is an active new therapeutic strategy in lymphoma models.
Gaudio E, Tarantelli C, Spriano F, Guidetti F, Sartori G, Bordone R, Arribas AJ, Cascione L, Bigioni M, Merlino G, Fiascarelli A, Bressan A, Adjeiwaa Mensah A, Golino G, Lucchini R, Bernasconi E, Rossi D, Zucca E, Stussi G, Stathis A, Boyd RS, Dusek RL, Bisht A, Attanasio N, Rohlff C, Pellacani A, Binaschi M, Bertoni F. Gaudio E, et al. Among authors: zucca e. Haematologica. 2020 Nov 1;105(11):2584-2591. doi: 10.3324/haematol.2019.227215. Haematologica. 2020. PMID: 33131247 Free PMC article.
Genetic and phenotypic attributes of splenic marginal zone lymphoma.
Bonfiglio F, Bruscaggin A, Guidetti F, Terzi di Bergamo L, Faderl M, Spina V, Condoluci A, Bonomini L, Forestieri G, Koch R, Piffaretti D, Pini K, Pirosa MC, Cittone MG, Arribas A, Lucioni M, Ghilardi G, Wu W, Arcaini L, Baptista MJ, Bastidas G, Bea S, Boldorini R, Broccoli A, Buehler MM, Canzonieri V, Cascione L, Ceriani L, Cogliatti S, Corradini P, Derenzini E, Devizzi L, Dietrich S, Elia AR, Facchetti F, Gaidano G, Garcia JF, Gerber B, Ghia P, Gomes da Silva M, Gritti G, Guidetti A, Hitz F, Inghirami G, Ladetto M, Lopez-Guillermo A, Lucchini E, Maiorana A, Marasca R, Matutes E, Meignin V, Merli M, Moccia A, Mollejo M, Montalban C, Novak U, Oscier DG, Passamonti F, Piazza F, Pizzolitto S, Rambaldi A, Sabattini E, Salles G, Santambrogio E, Scarfò L, Stathis A, Stüssi G, Geyer JT, Tapia G, Tarella C, Thieblemont C, Tousseyn T, Tucci A, Vanini G, Visco C, Vitolo U, Walewska R, Zaja F, Zenz T, Zinzani PL, Khiabanian H, Calcinotto A, Bertoni F, Bhagat G, Campo E, De Leval L, Dirnhofer S, Pileri SA, Piris MA, Traverse-Glehen A, Tzankov A, Paulli M, Ponzoni M, Mazzucchelli L, Cavalli F, Zucca E, Rossi D. Bonfiglio F, et al. Among authors: zucca e. Blood. 2022 Feb 3;139(5):732-747. doi: 10.1182/blood.2021012386. Blood. 2022. PMID: 34653238 Free article.
Marginal-Zone Lymphomas.
Rossi D, Bertoni F, Zucca E. Rossi D, et al. Among authors: zucca e. N Engl J Med. 2022 Feb 10;386(6):568-581. doi: 10.1056/NEJMra2102568. N Engl J Med. 2022. PMID: 35139275 Review. No abstract available.
Resistance to PI3Kδ inhibitors in marginal zone lymphoma can be reverted by targeting the IL-6/PDGFRA axis.
Arribas AJ, Napoli S, Cascione L, Sartori G, Barnabei L, Gaudio E, Tarantelli C, Mensah AA, Spriano F, Zucchetto A, Rossi FM, Rinaldi A, Castro de Moura M, Jovic S, Bordone-Pittau R, Di Veroli A, Stathis A, Cruciani G, Stussi G, Gattei V, Brown JR, Esteller M, Zucca E, Rossi D, Bertoni F. Arribas AJ, et al. Among authors: zucca e. Haematologica. 2022 Nov 1;107(11):2685-2697. doi: 10.3324/haematol.2021.279957. Haematologica. 2022. PMID: 35484662 Free PMC article.
Marginal-Zone Lymphomas. Reply.
Bertoni F, Rossi D, Zucca E. Bertoni F, et al. Among authors: zucca e. N Engl J Med. 2022 May 19;386(20):1962-1963. doi: 10.1056/NEJMc2203319. N Engl J Med. 2022. PMID: 35584172 No abstract available.
Bacterial infection-driven lymphomagenesis.
Vannata B, Pirosa MC, Bertoni F, Rossi D, Zucca E. Vannata B, et al. Among authors: zucca e. Curr Opin Oncol. 2022 Sep 1;34(5):454-463. doi: 10.1097/CCO.0000000000000886. Epub 2022 Jul 25. Curr Opin Oncol. 2022. PMID: 35880463 Review.
The bromodomain and extra-terminal domain degrader MZ1 exhibits preclinical anti-tumoral activity in diffuse large B-cell lymphoma of the activated B cell-like type.
Tarantelli C, Cannas E, Ekeh H, Moscatello C, Gaudio E, Cascione L, Napoli S, Rech C, Testa A, Maniaci C, Rinaldi A, Zucca E, Stathis A, Ciulli A, Bertoni F. Tarantelli C, et al. Among authors: zucca e. Explor Target Antitumor Ther. 2021;2(6):586-601. doi: 10.37349/etat.2021.00065. Epub 2021 Dec 31. Explor Target Antitumor Ther. 2021. PMID: 36046113 Free PMC article.
Marginal zone lymphomas.
Zucca E, Rossi D, Bertoni F. Zucca E, et al. Hematol Oncol. 2023 Jun;41 Suppl 1:88-91. doi: 10.1002/hon.3152. Hematol Oncol. 2023. PMID: 37294969 Review.
ETS1 phosphorylation at threonine 38 is associated with the cell of origin of diffuse large B cell lymphoma and sustains the growth of tumour cells.
Chung EYL, Sartori G, Ponzoni M, Cascione L, Priebe V, Xu-Monette ZY, Fang X, Zhang M, Visco C, Tzankov A, Rinaldi A, Sgrignani J, Zucca E, Rossi D, Cavalli A, Inghirami G, Scott DW, Young KH, Bertoni F. Chung EYL, et al. Among authors: zucca e. Br J Haematol. 2023 Oct;203(2):244-254. doi: 10.1111/bjh.19018. Epub 2023 Aug 16. Br J Haematol. 2023. PMID: 37584198
The ATR inhibitor elimusertib exhibits anti-lymphoma activity and synergizes with the PI3K inhibitor copanlisib.
Sartori G, Tarantelli C, Spriano F, Gaudio E, Cascione L, Mascia M, Barreca M, Arribas AJ, Licenziato L, Golino G, Ferragamo A, Pileri S, Damia G, Zucca E, Stathis A, Politz O, Wengner AM, Bertoni F. Sartori G, et al. Among authors: zucca e. Br J Haematol. 2024 Jan;204(1):191-205. doi: 10.1111/bjh.19218. Epub 2023 Nov 27. Br J Haematol. 2024. PMID: 38011941
PI3Kδ activation, IL6 over-expression, and CD37 loss cause resistance to the targeting of CD37-positive lymphomas with the antibody-drug conjugate naratuximab emtansine.
Arribas AJ, Gaudio E, Napoli S, Yvon Herbaux CJ, Tarantelli C, Bordone RP, Cascione L, Munz N, Aresu L, Sgrignani J, Rinaldi A, Kwee I, Rossi D, Cavalli A, Zucca E, Stussi G, Stathis A, Sloss C, Davids MS, Bertoni F. Arribas AJ, et al. Among authors: zucca e. bioRxiv [Preprint]. 2023 Nov 16:2023.11.14.566994. doi: 10.1101/2023.11.14.566994. bioRxiv. 2023. PMID: 38014209 Free PMC article. Preprint.
ERBB4-Mediated Signaling Is a Mediator of Resistance to PI3K and BTK Inhibitors in B-cell Lymphoid Neoplasms.
Arribas AJ, Napoli S, Cascione L, Barnabei L, Sartori G, Cannas E, Gaudio E, Tarantelli C, Mensah AA, Spriano F, Zucchetto A, Rossi FM, Rinaldi A, Castro de Moura M, Jovic S, Bordone Pittau R, Stathis A, Stussi G, Gattei V, Brown JR, Esteller M, Zucca E, Rossi D, Bertoni F. Arribas AJ, et al. Among authors: zucca e. Mol Cancer Ther. 2024 Mar 4;23(3):368-380. doi: 10.1158/1535-7163.MCT-23-0068. Mol Cancer Ther. 2024. PMID: 38052765
Targeting CD19-positive lymphomas with the antibodydrug conjugate loncastuximab tesirine: preclinical evidence of activity as a single agent and in combination therapy.
Tarantelli C, Wald D, Munz N, Spriano F, Bruscaggin A, Cannas E, Cascione L, Gaudio E, Arribas AJ, Manjappa S, Golino G, Scalise L, Cacciapuoti MT, Zucca E, Stathis A, Inghirami G, Van Berkel PH, Rossi D, Caimi PF, Zammarchi F, Bertoni F. Tarantelli C, et al. Among authors: zucca e. Haematologica. 2024 Oct 1;109(10):3314-3326. doi: 10.3324/haematol.2023.284197. Haematologica. 2024. PMID: 38721745 Free PMC article.
A first-in-class Wiskott-Aldrich syndrome protein activator with antitumor activity in hematologic cancers.
Spriano F, Sartori G, Sgrignani J, Barnabei L, Arribas AJ, Guala M, Del Amor AMC, Tomasso MR, Tarantelli C, Cascione L, Golino G, Riveiro ME, Bortolozzi R, Lupia A, Paduano F, Huguet S, Rezai K, Rinaldi A, Margheriti F, Ventura P, Guarda G, Costa G, Rocca R, Furlan A, Verdonk LM, Innocenti P, Martin NI, Viola G, Driessen C, Zucca E, Stathis A, Gahtory D, Van den Nieuwboer M, Bornhauser B, Alcaro S, Trapasso F, Cristobal S, Padrick SB, Pazzi N, Cavalli F, Cavalli A, Gaudio E, Bertoni F. Spriano F, et al. Among authors: zucca e. Haematologica. 2024 Nov 1;109(11):3602-3614. doi: 10.3324/haematol.2022.282672. Haematologica. 2024. PMID: 38899342 Free PMC article.
IL-16 production is a mechanism of resistance to BTK inhibitors and R-CHOP in lymphomas.
Arribas AJ, Guidetti F, Cannas E, Cascione L, Napoli S, Sartori G, Fuzio F, Pesenti E, Tarantelli C, Spriano F, Zucchetto A, Rossi FM, Bruscaggin A, Rinaldi A, Castro de Moura M, Jovic S, Raimondi A, Pittau RB, Terzi di Bergamo L, Ye X, Stathis A, Ben-David Y, Pan-Hammarström Q, Simonetta F, Stussi G, Zucca E, Gattei V, Brown JR, Esteller M, Rossi D, Bertoni F. Arribas AJ, et al. Among authors: zucca e. bioRxiv [Preprint]. 2025 May 10:2025.05.07.652612. doi: 10.1101/2025.05.07.652612. bioRxiv. 2025. PMID: 40654846 Free PMC article. Preprint.
Molecular basis of mantle cell lymphoma.
Bertoni F, Zucca E, Cotter FE. Bertoni F, et al. Among authors: zucca e. Br J Haematol. 2004 Jan;124(2):130-40. doi: 10.1046/j.1365-2141.2003.04761.x. Br J Haematol. 2004. PMID: 14687022 Review. No abstract available.
Genomic and expression profiling identifies the B-cell associated tyrosine kinase Syk as a possible therapeutic target in mantle cell lymphoma.
Rinaldi A, Kwee I, Taborelli M, Largo C, Uccella S, Martin V, Poretti G, Gaidano G, Calabrese G, Martinelli G, Baldini L, Pruneri G, Capella C, Zucca E, Cotter FE, Cigudosa JC, Catapano CV, Tibiletti MG, Bertoni F. Rinaldi A, et al. Among authors: zucca e. Br J Haematol. 2006 Feb;132(3):303-16. doi: 10.1111/j.1365-2141.2005.05883.x. Br J Haematol. 2006. PMID: 16409295
Genome-wide DNA analysis identifies recurrent imbalances predicting outcome in chronic lymphocytic leukaemia with 17p deletion.
Forconi F, Rinaldi A, Kwee I, Sozzi E, Raspadori D, Rancoita PM, Scandurra M, Rossi D, Deambrogi C, Capello D, Zucca E, Marconi D, Bomben R, Gattei V, Lauria F, Gaidano G, Bertoni F. Forconi F, et al. Among authors: zucca e. Br J Haematol. 2008 Nov;143(4):532-6. doi: 10.1111/j.1365-2141.2008.07373.x. Epub 2008 Aug 24. Br J Haematol. 2008. PMID: 18752589
Molecular and clinical features of chronic lymphocytic leukaemia with stereotyped B cell receptors: results from an Italian multicentre study.
Bomben R, Dal Bo M, Capello D, Forconi F, Maffei R, Laurenti L, Rossi D, Del Principe MI, Zucchetto A, Bertoni F, Rossi FM, Bulian P, Cattarossi I, Ilariucci F, Sozzi E, Spina V, Zucca E, Degan M, Lauria F, Del Poeta G, Efremov DG, Marasca R, Gaidano G, Gattei V. Bomben R, et al. Among authors: zucca e. Br J Haematol. 2009 Feb;144(4):492-506. doi: 10.1111/j.1365-2141.2008.07469.x. Epub 2008 Nov 19. Br J Haematol. 2009. PMID: 19036101
The NF-{kappa}B negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomas.
Novak U, Rinaldi A, Kwee I, Nandula SV, Rancoita PM, Compagno M, Cerri M, Rossi D, Murty VV, Zucca E, Gaidano G, Dalla-Favera R, Pasqualucci L, Bhagat G, Bertoni F. Novak U, et al. Among authors: zucca e. Blood. 2009 May 14;113(20):4918-21. doi: 10.1182/blood-2008-08-174110. Epub 2009 Mar 3. Blood. 2009. PMID: 19258598 Free PMC article.
Genomic profiling of Richter's syndrome: recurrent lesions and differences with de novo diffuse large B-cell lymphomas.
Scandurra M, Rossi D, Deambrogi C, Rancoita PM, Chigrinova E, Mian M, Cerri M, Rasi S, Sozzi E, Forconi F, Ponzoni M, Moreno SM, Piris MA, Inghirami G, Zucca E, Gattei V, Rinaldi A, Kwee I, Gaidano G, Bertoni F. Scandurra M, et al. Among authors: zucca e. Hematol Oncol. 2010 Jun;28(2):62-7. doi: 10.1002/hon.932. Hematol Oncol. 2010. PMID: 20014148
IGHD3-3 fails to behave as unfavourable prognostic marker in chronic lymphocytic leukaemia.
Bomben R, Dal Bo M, Capello D, Forconi F, Bertoni F, Maffei R, Laurenti L, Rossi D, Zucca E, Degan M, Marasca R, Efremov DG, Del Poeta G, Gaidano G, Gattei V. Bomben R, et al. Among authors: zucca e. Br J Haematol. 2010 Apr;149(2):299-302. doi: 10.1111/j.1365-2141.2009.08046.x. Epub 2009 Jan 7. Br J Haematol. 2010. PMID: 20064162 No abstract available.
Expression of mutated IGHV3-23 genes in chronic lymphocytic leukemia identifies a disease subset with peculiar clinical and biological features.
Bomben R, Dal-Bo M, Benedetti D, Capello D, Forconi F, Marconi D, Bertoni F, Maffei R, Laurenti L, Rossi D, Del Principe MI, Luciano F, Sozzi E, Cattarossi I, Zucchetto A, Rossi FM, Bulian P, Zucca E, Nicoloso MS, Degan M, Marasca R, Efremov DG, Del Poeta G, Gaidano G, Gattei V. Bomben R, et al. Among authors: zucca e. Clin Cancer Res. 2010 Jan 15;16(2):620-8. doi: 10.1158/1078-0432.CCR-09-1638. Epub 2010 Jan 12. Clin Cancer Res. 2010. PMID: 20068100
Syk expression patterns differ among B-cell lymphomas.
Ponzoni M, Uccella S, Mian M, Rinaldi A, Facchetti F, Pruneri G, Gaidano G, Capella C, Zucca E, Doglioni C, Bertoni F. Ponzoni M, et al. Among authors: zucca e. Leuk Res. 2010 Sep;34(9):e243-5. doi: 10.1016/j.leukres.2010.03.026. Epub 2010 Apr 7. Leuk Res. 2010. PMID: 20378171 No abstract available.
In vitro efficacy of tyrosine kinase inhibitors: SYK and BCR-ABL inhibitors in lymphomas.
Rinaldi A, Ponzoni M, Uccella S, Rossi D, Gaidano G, Facchetti F, Pruneri G, Tibiletti MG, Capella C, Zucca E, Doglioni C, Catapano C, Bertoni F. Rinaldi A, et al. Among authors: zucca e. Hematol Oncol. 2011 Sep;29(3):164-6. doi: 10.1002/hon.981. Epub 2011 Mar 17. Hematol Oncol. 2011. PMID: 21416481 Free article. No abstract available.
Chromosome 11q23.1 is an unstable region in B-cell tumor cell lines.
Poretti G, Kwee I, Bernasconi B, Rancoita PM, Rinaldi A, Capella C, Zucca E, Neri A, Tibiletti MG, Bertoni F. Poretti G, et al. Among authors: zucca e. Leuk Res. 2011 Jun;35(6):808-13. doi: 10.1016/j.leukres.2010.10.032. Epub 2011 Mar 21. Leuk Res. 2011. PMID: 21420167
Genome-wide DNA profiling better defines the prognosis of chronic lymphocytic leukaemia.
Rinaldi A, Mian M, Kwee I, Rossi D, Deambrogi C, Mensah AA, Forconi F, Spina V, Cencini E, Drandi D, Ladetto M, Santachiara R, Marasca R, Gattei V, Cavalli F, Zucca E, Gaidano G, Bertoni F. Rinaldi A, et al. Among authors: zucca e. Br J Haematol. 2011 Sep;154(5):590-9. doi: 10.1111/j.1365-2141.2011.08789.x. Epub 2011 Jul 12. Br J Haematol. 2011. PMID: 21749360
IGHV gene mutational status and 17p deletion are independent molecular predictors in a comprehensive clinical-biological prognostic model for overall survival prediction in chronic lymphocytic leukemia.
Bulian P, Rossi D, Forconi F, Del Poeta G, Bertoni F, Zucca E, Montillo M, Pozzato G, D'Arena G, Efremov DG, Marasca R, Lauria F, Gaidano G, Gattei V, Laurenti L. Bulian P, et al. Among authors: zucca e. J Transl Med. 2012 Jan 30;10:18. doi: 10.1186/1479-5876-10-18. J Transl Med. 2012. PMID: 22289136 Free PMC article.
Gains of CCND3 gene in ocular adnexal MALT lymphomas: an integrated analysis.
Li ZM, Spagnuolo L, Mensah AA, Rinaldi A, Bhagat G, Zucca E, Doglioni C, Ferreri AJ, Ponzoni M, Bertoni F. Li ZM, et al. Among authors: zucca e. Br J Haematol. 2013 Mar;160(5):719-22. doi: 10.1111/bjh.12161. Epub 2012 Dec 13. Br J Haematol. 2013. PMID: 23240690 No abstract available.
Risk factors of central nervous system relapse in mantle cell lymphoma.
Conconi A, Franceschetti S, Lobetti-Bodoni C, Stathis A, Margiotta-Casaluci G, Ramponi A, Mazzucchelli L, Bertoni F, Ghielmini M, Gaidano G, Cavalli F, Zucca E. Conconi A, et al. Among authors: zucca e. Leuk Lymphoma. 2013 Sep;54(9):1908-14. doi: 10.3109/10428194.2013.767454. Epub 2013 Feb 20. Leuk Lymphoma. 2013. PMID: 23339449
Large genomic aberrations detected by SNP array are independent prognosticators of a shorter time to first treatment in chronic lymphocytic leukemia patients with normal FISH.
Mian M, Rinaldi A, Mensah AA, Rossi D, Ladetto M, Forconi F, Marasca R, Uhr M, Stussi G, Kwee I, Cavalli F, Gaidano G, Zucca E, Bertoni F. Mian M, et al. Among authors: zucca e. Ann Oncol. 2013 May;24(5):1378-84. doi: 10.1093/annonc/mds646. Epub 2013 Jan 31. Ann Oncol. 2013. PMID: 23372049 Free article.
Genome-wide high resolution DNA profiling of hairy cell leukaemia.
Rinaldi A, Kwee I, Young KH, Zucca E, Gaidano G, Forconi F, Bertoni F. Rinaldi A, et al. Among authors: zucca e. Br J Haematol. 2013 Aug;162(4):566-9. doi: 10.1111/bjh.12393. Epub 2013 May 21. Br J Haematol. 2013. PMID: 23692203 No abstract available.
Prognostic impact of monocyte count at presentation in mantle cell lymphoma.
von Hohenstaufen KA, Conconi A, de Campos CP, Franceschetti S, Bertoni F, Margiotta Casaluci G, Stathis A, Ghielmini M, Stussi G, Cavalli F, Gaidano G, Zucca E. von Hohenstaufen KA, et al. Among authors: zucca e. Br J Haematol. 2013 Aug;162(4):465-73. doi: 10.1111/bjh.12409. Epub 2013 Jun 29. Br J Haematol. 2013. PMID: 23808798
496 results